SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-010932
Filing Date
2015-02-09
Accepted
2015-02-09 17:30:39
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3312
  Complete submission text file 0001209191-15-010932.txt   4820
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2400 BAYSHORE PARKWAY SUITE 200 MOUNTAIN VIEW CA 94043
Business Address
SHREWSBURY STEPHEN B (Reporting) CIK: 0001413821 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36327 | Film No.: 15589623